IFRS substantially influences the Life Sciences market, not only in terms of practical transitional issues, but also in respect to reportable earnings, net asset value, the level of gearing, and return on capital employed. In this IFRS benchmark study, we have analysed the financial statements of 20 European Life Sciences companies that have prepared their financial statements for 2005 in accordance with IFRS.
Publications Search Page
|
|
